Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors
ObjectiveThe addition of cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) to endocrine therapy impressively improved the outcome of patients with hormone receptor-positive metastatic breast cancer. Despite their great efficacy, not all patients respond to treatment and many of them develop acquired...
Main Authors: | Alessio Annovazzi, Sandra Rea, Daria Maccora, Laura Pizzuti, Gianluigi Ferretti, Patrizia Vici, Federico Cappuzzo, Rosa Sciuto |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1193174/full |
Similar Items
-
Imaging Features and Prognostic Value of FDG PET/CT in Patients with Intravascular Large B-Cell Lymphoma
by: Lim CH, et al.
Published: (2021-09-01) -
Radiomic analysis will add differential diagnostic value of benign and malignant pulmonary nodules: a hybrid imaging study based on [18F]FDG and [18F]FLT PET/CT
by: Jing Ning, et al.
Published: (2023-11-01) -
Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing
by: Jason Michael Johnson, et al.
Published: (2021-11-01) -
Differentiating malignant and benign pleural effusion in patients with lung cancer: an 18F-FDG PET/CT retrospectively study
by: Weishan Zhang, et al.
Published: (2023-06-01) -
FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study
by: Ya-Nan Ou, et al.
Published: (2019-06-01)